Secim Kolak
Konya, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Determining the clinical impact of attack triggers in patients with hereditary angioedema.
Journal: Allergy and asthma proceedings
Published: September 05, 2026
Comparative Safety and Treatment Persistence of Aeroallergen and Venom Immunotherapy: A Real-World Patient- and Injection-Level Analysis.
Journal: International archives of allergy and immunology
Published: July 31, 2026
Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.
Journal: Allergy and asthma proceedings
Published: June 25, 2026
Prevalence, associated clinical factors, and genetic characteristics of endocrinopathies in common variable immunodeficiency: a retrospective study of 95 adult patients from a single tertiary care center.
Journal: Frontiers in immunology
Published: May 15, 2026
Clinical and immunological factors associated with gastrointestinal involvement in common variable immunodeficiency: a real-world study.
Journal: BMC immunology
Published: April 28, 2026
Psychological Symptom Burden after Anaphylaxis in Adults: A Cross-Sectional Study.
Journal: International archives of allergy and immunology
Published: April 06, 2026
Comparison of clinical characteristics in primary immunodeficiency patients based on the presence of autoimmunity or autoinflammation.
Journal: Allergy and asthma proceedings
Published: March 17, 2026
Age-Related Phenotypic Divergence in Nonsteroidal Anti-Inflammatory Drug Hypersensitivity: Clinical and Comorbidity Correlates.
Journal: International archives of allergy and immunology
Published: January 15, 2026
Real-World Outcomes of Rapid Drug Desensitization for Taxane and Platinum Chemotherapy.
Journal: International archives of allergy and immunology
Published: December 09, 2025
Comparison of prognostic models for predicting severe noninfectious complications in common variable immunodeficiency.
Journal: Allergologia et immunopathologia
Published: October 20, 2025
Clinical and Laboratory Predictors of Relapse within One Year after Omalizumab Discontinuation in Chronic Spontaneous Urticaria: A Real-Life Cohort Study.
Journal: International archives of allergy and immunology
Published: October 17, 2025
Effect of age on omalizumab response in chronic urticaria: a retrospective comparison between adult and geriatric populations.
Journal: Allergologia et immunopathologia
Published: September 17, 2025
Last Updated: 09/26/2026